Prostate Cancer - Results from #18960

Clinical phenotypes associated with circulating tumor cell enumeration in metastatic castration-resistant prostate cancer - Abstract March 13, 2015

Brachytherapy improves biochemical failure-free survival in low- and intermediate-risk prostate cancer compared with conventionally fractionated external beam radiation therapy: A propensity score matched analysis - Abstract March 13, 2015

Gastrointestinal dose-histogram effects in the context of dose-volume-constrained prostate radiation therapy: Analysis of data from the RADAR Prostate Radiation Therapy trial - Abstract March 13, 2015

Reduction in hospital admissions with the addition of prophylactic intramuscular ceftriaxone before transrectal ultrasonography-guided prostate biopsies - Abstract March 13, 2015

18F-Fluoride PET used for treatment monitoring of systemic cancer therapy: Results from the National Oncologic PET Registry - Abstract March 13, 2015

ADT risks and side effects in advanced prostate cancer: Cardiovascular and acute renal injury - Abstract March 12, 2015

Chronic inflammatory mediators enhance prostate cancer development and progression - Abstract March 12, 2015

Improvements in radiographic progression-free survival stratified by ERG gene status in castration-resistant prostate cancer patients treated with abiraterone - Abstract March 12, 2015

Anterior-oriented proton beams for prostate cancer: A multi-institutional experience - Abstract March 12, 2015

Positron emission tomography for molecular imaging of prostate cancer - Abstract March 12, 2015

Is modern external beam radiotherapy with androgen deprivation therapy still a viable alternative for prostate cancer in an era of robotic surgery and brachytherapy: A comparison of Australian series - Abstract March 12, 2015

The fat body mass increase after adjuvant androgen deprivation therapy is predictive of prostate cancer outcome - Abstract March 12, 2015

Comparing morbidity and cancer control after 3D-conformal (70/74 Gy) and intensity modulated radiotherapy (78/82 Gy) for prostate cancer - Abstract March 12, 2015

Radiation-induced second primary cancer risks from modern external beam radiotherapy for early prostate cancer: - Abstract March 12, 2015

Multiparametric magnetic resonance imaging/transrectal ultrasound fusion targeted biopsy of the prostate: Preliminary results of a prospective single-centre study - Abstract March 12, 2015

Establishing implantation uncertainties for focal brachytherapy with I-125 seeds for the treatment of localized prostate cancer - Abstract March 12, 2015

#GU15 - AR splice variant 7 (AR-V7) could be a marker for treatment selection in metastatic castrate-resistant prostate cancer March 11, 2015

Current role of cabozantinib in metastatic castration-resistant prostate cancer - Abstract March 11, 2015

Prostate-specific membrane antigen-based imaging in prostate cancer: Impact on clinical decision making process - Abstract March 11, 2015

GPs could play key role in prostate cancer survivorship programmes - Abstract March 11, 2015

Page 949 of 1457